Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
SynopsisP

Enhanced surveillance for Salmonella Newport

Erica Weir, Kathryn Doré and Andrea Currie
CMAJ July 20, 2004 171 (2) 127-128; DOI: https://doi.org/10.1503/cmaj.1041038
Erica Weir
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn Doré
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Currie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

Background and epidemiology: Between Apr. 1 and Dec. 31, 2004, Health Canada, in collaboration with provincial and territorial governments, is undertaking enhanced surveillance for Salmonella enterica serotype Newport. Physicians are urged to collect stool specimens for suspected cases of salmonellosis as part of this initiative, which resulted from several disturbing trends observed in North America. Over the past few years, there has been a rapid increase in the number of laboratory-confirmed Salmonella Newport infections reported to the US Centers for Disease Control and Prevention (CDC).1 The spectrum of illness, which includes bloody diarrhea, tends to be quite severe2 and, according to the US National Antimicrobial Resistance Monitoring System for Enteric Bacteria, an increasing number of Salmonella Newport isolates are multidrug resistant, with the proportion of isolates resistant to 9 or more antimicrobial agents increasing from 1% in 1998 to 26% in 2001.2 Some of these isolates also demonstrate reduced susceptibility to ceftriaxone, a third-generation cephalosporin commonly used to treat invasive Salmonella infections.

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure. Photo by: Art Explosion

In 2002 the CDC reported an outbreak of Salmonella Newport involving 47 people in 5 states, 4 of which bordered Canada. Investigation of these cases implicated exposure to raw or undercooked ground beef. The following year, Ontario veterinarians were alerted to a newly detected multidrug-resistant Salmonella Newport and its rising incidence in bovine populations, primarily dairy cattle.3 Three clusters of infected cattle were identified in Ontario; there were also sporadic human cases reported in Canada, at least 2 of which were related to the bovine outbreaks in Ontario. The strains isolated from these outbreaks were resistant to 9 or more antimicrobial agents and demonstrated intermediate resistance to ceftriaxone. According to the Canadian Integrated Program for Antimicrobial Resistance Surveillance and the National Microbiology Laboratory, these extensive resistance profiles had not been observed among isolates from human sources before 2003.4

Direct exposure to a dairy farm, ingestion of raw milk and unpasteurized cheese, and consumption of raw or undercooked ground beef are likely risk factors for human infection.2 The purpose of Health Canada's enhanced surveillance is to increase the understanding of the burden of illness and the risk factors contributing to multidrug-resistant Salmonella Newport infections in Canada.

Clinical management: The symptoms of salmonellosis include nausea and vomiting, abdominal cramps, diarrhea, fever and headache. They can appear from 6 to 48 hours after infection with the Salmonella bacteria and usually last 1 or 2 days; however, they may be protracted in infants, elderly people and people with a weakened immune system. After 3 or 4 weeks arthritis may appear in some cases. Although antimicrobial agents are not needed in most cases of Salmonella infection, they may be life-saving in invasive infections.

Physicians are strongly encouraged to collect stool specimens from patients with suspected salmonellosis, particularly if there is a history of recent exposure to a dairy farm. For the purposes of enhanced surveillance, specimens from positive Salmonella cultures will be forwarded to provincial public health laboratories and the National Microbiology Laboratory for serotyping and antimicrobial-resistance testing. Public health units will be notified of laboratory-confirmed cases of Salmonella Newport infection, and health unit staff will interview cases about the illness event, risk factors (e.g., antecedent antimicrobial use) and burden of illness.

Prevention: Farming practices such as intensive farming, the tremendous movement of cattle between farms and the overuse of antimicrobial agents have probably contributed to the emergence of multidrug-resistant Salmonella Newport. Ceftiotur, an extended-spectrum cephalosporin, is commonly used therapeutically in dairy cattle, and antimicrobial agents such as tetracycline and neomycin are used prophylactically in calf milk replacers.2

Unsafe food handling and preparation are also contributing factors. Encouraging industry to implement processes such as steam pasteurization and irradiation of ground beef may reduce the risk of exposure.1 Patients should be reminded that meat and eggs need to be cooked to an internal temperature of 71°C (www.eatwelleatsafe.ca/inhome/temp.htm), and utensils and surfaces used to prepare raw food should never come in contact with cooked food or foods that will be eaten raw.

Infected patients should be isolated from other household members and instructed to wash their hands. They should get time off work if working in the food industry or in health care facilities or if looking after people with risk factors such as immunosupression and chronic diseases such as those in nursing homes. Infected patients should have 2 consecutive negative stool samples before returning to work or normal living.

Erica Weir Associate Medical Officer of Health Kingston, Frontenac and Lennox & Addington Health Unit Kingston, Ont. Kathryn Doré Acting Manager, Surveillance Section Andrea Currie Epidemiologist Foodborne, Waterborne and Zoonotic Infections Division Centre for Infectious Disease Prevention and Control Population and Public Health Branch Health Canada, Guelph, Ont.

References

  1. 1.↵
    Outbreak of multidrug-resistant Salmonella Newport — United States, January–April 2002. MMWR Morb Mortal Wkly Rep 2002;51(25):545-8.
    OpenUrlPubMed
  2. 2.↵
    Gupta A, Fontana J, Crowe C, Bolstorff B, Stout A, Van Duyne S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Newport infections resistant to expanded- spectrum cephalosporins in the United States. J Infect Dis 2003;188:1707-16.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Innes P. Multi-drug resistant Salmonella Newport. Toronto: Ontario Ministry of Agriculture and Food; 2003. Available: www.gov.on.ca/OMAFRA/english/livestock/vet/facts/info_salm.htm (accessed 2004 June 23).
  4. 4.↵
    Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS). Ottawa: Health Canada; 2002. Available: (English) www.hc-sc.gc.ca/pphb-dgspsp/cipars-picra/index.html (accessed 2004 June 23).
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 171 (2)
CMAJ
Vol. 171, Issue 2
20 Jul 2004
  • Table of Contents
  • Index by author

Article tools

Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Enhanced surveillance for Salmonella Newport
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Enhanced surveillance for Salmonella Newport
Erica Weir, Kathryn Doré, Andrea Currie
CMAJ Jul 2004, 171 (2) 127-128; DOI: 10.1503/cmaj.1041038

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Enhanced surveillance for Salmonella Newport
Erica Weir, Kathryn Doré, Andrea Currie
CMAJ Jul 2004, 171 (2) 127-128; DOI: 10.1503/cmaj.1041038
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Salmonella Newport Bacteremia in a 12-Day-Old Infant
  • Google Scholar

More in this TOC Section

  • Applying the 2005 Canadian Hypertension Education Program recommendations: 4. Managing uncomplicated hypertension
  • A newborn requiring selective bronchial intubation
  • Does β-blocker prophylaxis improve survival after major noncardiac surgery?
Show more Synopsis

Similar Articles

Collections

  • Topics
    • Infectious diseases

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of the resources on this site in an accessible format, please contact us at cmajgroup@cmaj.ca.

Powered by HighWire